These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 29054855)

  • 1. H- ras deletion protects against angiotensin II-induced arterial hypertension and cardiac remodeling through protein kinase G-Iβ pathway activation.
    Martín-Sánchez P; Luengo A; Griera M; Orea MJ; López-Olañeta M; Chiloeches A; Lara-Pezzi E; de Frutos S; Rodríguez-Puyol M; Calleros L; Rodríguez-Puyol D
    FASEB J; 2018 Feb; 32(2):920-934. PubMed ID: 29054855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DKK3 overexpression attenuates cardiac hypertrophy and fibrosis in an angiotensin-perfused animal model by regulating the ADAM17/ACE2 and GSK-3β/β-catenin pathways.
    Zhai CG; Xu YY; Tie YY; Zhang Y; Chen WQ; Ji XP; Mao Y; Qiao L; Cheng J; Xu QB; Zhang C
    J Mol Cell Cardiol; 2018 Jan; 114():243-252. PubMed ID: 29196099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. H-Ras Isoform Mediates Protection Against Pressure Overload-Induced Cardiac Dysfunction in Part Through Activation of AKT.
    Matsuda T; Jeong JI; Ikeda S; Yamamoto T; Gao S; Babu GJ; Zhai P; Del Re DP
    Circ Heart Fail; 2017 Feb; 10(2):. PubMed ID: 28193718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis signal-regulating kinase 1 plays a pivotal role in angiotensin II-induced cardiac hypertrophy and remodeling.
    Izumiya Y; Kim S; Izumi Y; Yoshida K; Yoshiyama M; Matsuzawa A; Ichijo H; Iwao H
    Circ Res; 2003 Oct; 93(9):874-83. PubMed ID: 14551246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressive Effects of Glucose-Dependent Insulinotropic Polypeptide on Cardiac Hypertrophy and Fibrosis in Angiotensin II-Infused Mouse Models.
    Hiromura M; Mori Y; Kohashi K; Terasaki M; Shinmura K; Negoro T; Kawashima H; Kogure M; Wachi T; Watanabe R; Sato K; Kushima H; Tomoyasu M; Nakano Y; Yamada Y; Watanabe T; Hirano T
    Circ J; 2016 Aug; 80(9):1988-97. PubMed ID: 27375170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HSF1 phosphorylation by ERK/GSK3 suppresses RNF126 to sustain IGF-IIR expression for hypertension-induced cardiomyocyte hypertrophy.
    Huang CY; Lee FL; Peng SF; Lin KH; Chen RJ; Ho TJ; Tsai FJ; Padma VV; Kuo WW; Huang CY
    J Cell Physiol; 2018 Feb; 233(2):979-989. PubMed ID: 28383811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects of endogenous adrenomedullin on cardiac hypertrophy, fibrosis, and renal damage.
    Niu P; Shindo T; Iwata H; Iimuro S; Takeda N; Zhang Y; Ebihara A; Suematsu Y; Kangawa K; Hirata Y; Nagai R
    Circulation; 2004 Apr; 109(14):1789-94. PubMed ID: 14967720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular ADAM17 as a Novel Therapeutic Target in Mediating Cardiovascular Hypertrophy and Perivascular Fibrosis Induced by Angiotensin II.
    Takayanagi T; Forrester SJ; Kawai T; Obama T; Tsuji T; Elliott KJ; Nuti E; Rossello A; Kwok HF; Scalia R; Rizzo V; Eguchi S
    Hypertension; 2016 Oct; 68(4):949-955. PubMed ID: 27480833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FKBP12.6 protects heart from AngII-induced hypertrophy through inhibiting Ca
    Xiao YF; Zeng ZX; Guan XH; Wang LF; Wang CJ; Shi H; Shou W; Deng KY; Xin HB
    J Cell Mol Med; 2018 Jul; 22(7):3638-3651. PubMed ID: 29682889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cardiac-enriched microRNA, miR-378, blocks cardiac hypertrophy by targeting Ras signaling.
    Nagalingam RS; Sundaresan NR; Gupta MP; Geenen DL; Solaro RJ; Gupta M
    J Biol Chem; 2013 Apr; 288(16):11216-32. PubMed ID: 23447532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of protein kinase B2 preserves cardiac function by blocking interleukin-6-mediated injury and restores blood pressure during angiotensin II/high-salt-diet-induced hypertension.
    Yang S; Chen D; Chen F; Zhao X; Zhang Y; Li Z; Jin L; Xu Y; Sanchis D; Ye J
    J Hypertens; 2018 Apr; 36(4):834-846. PubMed ID: 29120957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysyl oxidase overexpression accelerates cardiac remodeling and aggravates angiotensin II-induced hypertrophy.
    Galán M; Varona S; Guadall A; Orriols M; Navas M; Aguiló S; de Diego A; Navarro MA; García-Dorado D; Rodríguez-Sinovas A; Martínez-González J; Rodriguez C
    FASEB J; 2017 Sep; 31(9):3787-3799. PubMed ID: 28522596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpressed connective tissue growth factor in cardiomyocytes attenuates left ventricular remodeling induced by angiotensin II perfusion.
    Zhang Y; Yan H; Guang GC; Deng ZR
    Clin Exp Hypertens; 2017; 39(2):168-174. PubMed ID: 28287886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of adiponectin on cardiac β-catenin signaling pathway under angiotensin II infusion.
    Fujishima Y; Maeda N; Matsuda K; Komura N; Hirata A; Mori T; Sekimoto R; Tsushima Y; Nishizawa H; Funahashi T; Shimomura I
    Biochem Biophys Res Commun; 2014 Feb; 444(2):224-9. PubMed ID: 24462873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of soluble epoxide hydrolase attenuates cardiac hypertrophy via down-regulation of cardiac fibroblasts-derived fibroblast growth factor-2.
    Zhang H; Wang T; Zhang K; Liu Y; Huang F; Zhu X; Liu Y; Wang MH; Tang W; Wang J; Huang H
    Crit Care Med; 2014 May; 42(5):e345-54. PubMed ID: 24448199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IRF3 regulates cardiac fibrosis but not hypertrophy in mice during angiotensin II-induced hypertension.
    Tsushima K; Osawa T; Yanai H; Nakajima A; Takaoka A; Manabe I; Ohba Y; Imai Y; Taniguchi T; Nagai R
    FASEB J; 2011 May; 25(5):1531-43. PubMed ID: 21266535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium Ferulate Protects against Angiotensin II-Induced Cardiac Hypertrophy in Mice by Regulating the MAPK/ERK and JNK Pathways.
    Hu B; Song JT; Ji XF; Liu ZQ; Cong ML; Liu DX
    Biomed Res Int; 2017; 2017():3754942. PubMed ID: 28164119
    [No Abstract]   [Full Text] [Related]  

  • 18. Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction.
    Zhong J; Basu R; Guo D; Chow FL; Byrns S; Schuster M; Loibner H; Wang XH; Penninger JM; Kassiri Z; Oudit GY
    Circulation; 2010 Aug; 122(7):717-28, 18 p following 728. PubMed ID: 20679547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibulin-2 deficiency attenuates angiotensin II-induced cardiac hypertrophy by reducing transforming growth factor-β signalling.
    Zhang H; Wu J; Dong H; Khan SA; Chu ML; Tsuda T
    Clin Sci (Lond); 2014 Feb; 126(4):275-88. PubMed ID: 23841699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mnk1 (Mitogen-Activated Protein Kinase-Interacting Kinase 1) Deficiency Aggravates Cardiac Remodeling in Mice.
    Yuan Y; Yan L; Wu QQ; Zhou H; Jin YG; Bian ZY; Deng W; Yang Z; Shen DF; Zeng XF; Wang SS; Li H; Tang QZ
    Hypertension; 2016 Dec; 68(6):1393-1399. PubMed ID: 27698061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.